Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Recently published
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
B cells modulate mouse allergen-specific T cells in nonallergic laboratory animal-care workers
Esther Dawen Yu, … , Ricardo da Silva Antunes, Alessandro Sette
Esther Dawen Yu, … , Ricardo da Silva Antunes, Alessandro Sette
Published February 22, 2021
Citation Information: JCI Insight. 2021;6(4):e145199. https://doi.org/10.1172/jci.insight.145199.
View: Text | PDF
Research Article Immunology

B cells modulate mouse allergen-specific T cells in nonallergic laboratory animal-care workers

  • Text
  • PDF
Abstract

Understanding the mechanisms of allergen-specific immune modulation in nonallergic individuals is key to recapitulate immune tolerance and to develop novel allergy treatments. Herein, we characterized mouse-specific T cell responses in nonallergic laboratory animal-care workers before and after reexposure to mice. PBMCs were collected and stimulated with developed peptide pools identified from high-molecular-weight fractions of mouse allergen extracts. Sizable CD4 T cell responses were noted and were temporarily decreased in most subjects upon reexposure, with the magnitude of decrease positively correlated with time of reexposure but not the duration of the break. Interestingly, the suppression was specific to mouse allergens without affecting responses of bystander antigens. Further, PBMC fractioning studies illustrated that the modulation is unlikely from T cells, while B cell depletion and exchange reversed the suppression of responses, suggesting that B cells may be the key modulators. Increased levels of regulatory cytokines (IL-10 and TGF-β1) in the cell culture supernatant and plasma mouse-specific IgG4 were also observed after reexposure, consistent with B cell–mediated modulation mechanisms. Overall, these results suggest that nonallergic status is achieved by an active, time-related, allergen-specific, B cell-dependent regulatory process upon reexposure, the mechanisms of which should be detailed by further molecular studies.

Authors

Esther Dawen Yu, Luise Westernberg, Alba Grifoni, April Frazier, Aaron Sutherland, Eric Wang, Bjoern Peters, Ricardo da Silva Antunes, Alessandro Sette

×

Figure 1

Longitudinal study on exposed nonallergic mouse laboratory workers.

Options: View larger image (or click on image) Download as PowerPoint
Longitudinal study on exposed nonallergic mouse laboratory workers.
(A) ...
(A) Diagram illustrating the study design of the mouse longitudinal study. Blood samples were collected at 3 time points: pre-break (PRB), after break but pre-reexposure (PRE), and after reexposure (ARE) to mouse. (B and C) Decrease in CD4 T cell responses in nonallergic subjects after reexposure to mouse. Differences in T cell reactivity of 3 groups were detected using AIM assay (C, n = 36). AIM+ signals (4-1BB+OX40+) are represented by numbers per million of CD4 T cells. Data are plotted as median with interquartile range. Statistical analysis was performed by Wilcoxon’s test for paired comparison, with Bonferroni correction for multiple comparison. Time relationship of magnitude of T cell response inhibition was investigated with time of reexposure (D) and duration of break (E) using Spearman’s correlation test (n = 36). Percentage of inhibition = (1 – [ARE response]/[PRE response ]) × 100. (F) Plot of a nonlinear regression model based on cross-sectional data (n = 36) showing a trend of dynamic changes of CD4 T cell responses ARE. Relative percentage of response = (ARE response/PRE response) × 100. Nonlinear generalized additive model was performed using the mgcv package for R.
Follow JCI Insight:
Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts